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VISUAL ABSTRACT
Manning, J.R. et al. J Am Coll Cardiol Basic Trans Science. 2018;3(1):83–96.
HIGHLIGHTS
 Rad-GTPase is an LTCC component that
functions to govern calcium current in the
myocardium.
 Deletion of Rad increases myocardial
contractility secondary to increased
trigger calcium entry.
 AMI induces heart failure, including
reduced calcium homeostasis, but
deletion of Rad prevents AMI myocardial
calcium alterations.
 Rad deletion prevents post-MI scar spread
by attenuating the inflammatory
response.
 Future studies will explore whether Rad
deletion is an effective therapeutic
direction for providing combined safe,
stable inotropic support to the failing
heart in concert with protection against
inflammatory signaling.
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ª 2 0 1 8 T H E A U T H O R S . P U B L I S H E D B Y E L S E V I E R O N B E H A L F O F T H E A M E R I C A N
C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N . T H I S I S A N O P E N A C C E S S A R T I C L E U N D E R
T H E C C B Y - N C - N D L I C E N S E ( h t t p : / / c r e a t i v e c o mm o n s . o r g / l i c e n s e s / b y - n c - n d / 4 . 0 / ) .
SUMMARY
The protein Rad interacts with the L-type calcium channel complex to modulate trigger Ca2þ and hence to
govern contractility. Reducing Rad levels increases cardiac output. Ablation of Rad also attenuated the
inflammatory response following acute myocardial infarction. Future studies to target deletion of Rad in the
heart could be conducted to establish a novel treatment paradigm whereby pathologically stressed hearts
would be given safe, stable positive inotropic support without arrhythmias and without pathological structural
remodeling. Future investigations will also focus on establishing inhibitors of Rad and testing the efficacy of
Rad deletion in cardioprotection relative to the time of onset of acute myocardial infarction. (J Am Coll Cardiol
Basic Trans Science 2018;3:83–96) © 2018 The Authors. Published by Elsevier on behalf of the American College
of Cardiology Foundation. This is an open access article under the CCBY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
M yocardial infarction (MI) is aleading cause of death in theUnited States. A cardiac infarct
creates a zone containing noncontractile tis-
sue, which compromises the overall mechanical func-
tion of the heart. This depresses cardiac output and
triggers compensatory hypertrophic growth and
remodeling of the myocardium (1,2). Resulting ven-
tricular dilation creates a mechanical disadvantage
contributing to a vicious reflexive cycle leading to
decompensatory heart failure (heart failure with
reduced ejection fraction [HFrEF]). Impaired calcium
cycling is a cellular mechanism that contributes to the
loss of inotropy in HFrEF. An avenue for investigation
therefore becomes the recovery of systolic function
via the restoration of healthy calcium cycling. Current
treatment of post-MI HFrEF focuses on survival,
possibly via relieving cardiac work load using
b-adrenergic receptor inhibitors, volume control,
reducing cardiac afterload, and preventing further
injury from coronary obstruction. However, b-adren-
ergic receptor inhibition can often have unintended
noncardiac side effects and is contraindicated in pa-
tients with advanced heart failure. In fact, the
reduced contractility of the dilated left ventricle re-
duces cardiac output to such an extent that pharma-
cological enhancement of inotropy is required to
sustain blood pressure (3,4). In addition, comorbidity
often confounds treatment of injury, which can strike
patients with HFrEF already reliant on adrenergic
stimulation to maintain cardiac output (5), who are
at greater risk for death after MI (6). Investigation of
strategies that promote cardioprotection from MI
without compromising cardiac contractility is there-
fore of great interest. Proteins that interact with and
regulate the L-type calcium channel complex (LTCC)
are among this group.
Recent investigations into endogenous regulators
of the LTCC have shed light on RGK proteins, a family
of small Ras-like guanosine triphosphatases
(GTPases) (7–10). RGK proteins are differentially
expressed; Rad, an RGK protein expressed in abun-
dance in the heart, has a significant effect on cardiac
LTCC current. Rad eliminates current when overex-
pressed (11); conversely, Rad reduction significantly
increases LTCC conductance and twitch calcium (12).
We have observed improved contractile function at
the cellular and whole-heart levels in uninjured
hearts lacking Rad expression (12). This is under-
scored by the down-regulation of Rad in human heart
failure (13), consistent with compensatory regulation
to preserve cardiac output. Better systolic function is
also associated with improved outcomes after MI
(14,15), suggesting that Rad loss may also act as a
ABBR EV I A T I ON S
AND ACRONYMS
AMI = acute myocardial
infarction
EF = ejection fraction
GTPase = guanosine
triphosphatase
HFrEF = heart failure with
reduced ejection fraction
LAD = left anterior descending
coronary artery
LTCC = L-type calcium channel
complex
MI = myocardial infarction
PCR = polymerase chain
reaction
RNA = ribonucleic acid
WT = wild-type
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compensatory mechanism to recover function in
heart failure post-MI.
In addition to compromising function acutely,
cardiac ischemia triggers a series of signaling events
to communicate with peripheral blood cells and bone
marrow that may affect long-term contractile recov-
ery from MI (16). In the first wave of peripheral blood
cell response to acute MI (AMI), neutrophils aid in
cleanup after tissue damage and the release of pro-
teolytic enzymes. However, this initial injury
response may actually confer long-term harm because
reduction in the initial recruitment of inflammatory
cells reduces infarct size and prevents cardiac
remodeling after AMI in mice (16).
In this study, we evaluated the effect of Rad
deletion in the response of the myocardium to MI.
We found that Rad deletion reduces both mortality
and contractile dysfunction after MI. We also found
that Rad loss reduces scar development indepen-
dent of preserving tissue viability, and this
finding is accompanied by a reduction in the acute
inflammatory response of neutrophil extravasation
along with a decrease in inflammatory cytokine
signaling.
METHODS
Additional detailed methods are available in the
Supplemental Appendix.
MOUSE MODEL. Animals lacking Rad GTPase
expression were generated as previously described
(17). Cardiac infarct was generated via surgical liga-
tion of the left anterior descending coronary artery
(LAD) as previously described (18). All mice were
housed and bred on-site, according to the regulations
and standards of the University of Kentucky Institu-
tional Animal Care and Use Committee guidelines,
which conform to the National Institutes of Health
Guide for Care and Use of Laboratory Animals.
RIBONUCLEIC ACID ISOLATION, MICROARRAY, AND
QUANTITATIVE REVERSE-TRANSCRIPTION POLYMERASE
CHAIN REACTION. Twenty-four h after MI or sham
surgery, tissue from apical regions of the left ventricle
was snap frozen in liquid nitrogen. Frozen sections
were homogenized in Trizol (Invitrogen, Carlsbad,
California). Ribonucleic acid (RNA) was extracted
with chloroform followed by isopropanol precipita-
tion and an ethanol wash. The RNA pellet was then
treated with DNAse1 (Qiagen, Hilden, Germany) to
remove DNA, then precipitated in ammonium acetate
and ethanol. After resolubilization, RNA was quanti-
tated and evaluated for quality using the Agilent
Bioanalyzer RNA 6000 RNA Nano Kit (Agilent, Santa
Clara, California). A Mouse Gene 2.0 ST array was
used to probe for gene expression differences
between Rad/ and wild-type (WT) MI hearts for
sham and 24 h after LAD ligation. Candidate inflam-
matory genes identified by this array were validated
by quantitative reverse-transcription polymerase
chain reaction (PCR) using complementary deoxy-
ribonucleic acid generated with qScript (VWR,
Radnor, Pennsylvania) followed by quantitative PCR
using TaqMan probes for Il16, Il1b, Cxcl1, Cxcl2, Cxcr2,
and Tnf (Thermo Fisher Scientific, Waltham, Massa-
chusetts). Cycle threshold (CT) values were compared
to determine statistical significance between groups.
STATISTICAL ANALYSIS. All analyses were done us-
ing GraphPad Prism version 7.03 (GraphPad Software,
La Jolla, California). Survival curves were compared
using a Gehan-Breslow-Wilcoxon test for difference.
For simple comparisons between groups, a Student
t test (for large groups with a Gaussian distribution) or
Mann-Whitney U test (for small groups) was per-
formed. One-way analysis of variance (for large
groups with a Gaussian distribution) or a Kruskal-
Wallis test (for small groups) was used to determine
statistically significant differences between sham and
MI WT and Rad/ groups for single endpoints, fol-
lowed by the post hoc Holm-Sidak test (analysis of
variance) or Dunn’s multiple comparison’s test
(Kruskal-Wallis test) for individual comparisons. For
longitudinal studies examining multiple time points
(i.e., all echocardiography time courses, blood pres-
sure data), a repeated-measures 2-way analysis of
variance was used. A p value of <0.05 was considered
to indicate statistical significance. All values are
presented as the mean  SEM.
RESULTS
RAD DELETION PROTECTS AGAINST AMI-INDUCED
MORTALITY. In WT mice, mortality was observed
2 to 5 days after LAD ligation (Figure 1). Deceased mice
exhibited blood-filled thoracic cavities consistent
with ventricle rupture. No mortality was observed in
Rad/ mice that were ligated at the same time as the
WT cohorts, suggesting that Rad loss is protective
against ischemia-induced mortality (Figure 1A) (n ¼ 9
WT and 11 Rad/ mice). Longitudinal-axis echocar-
diography suggested that Rad/ had attenuated scar
spread at 4 weeks after LAD ligation (Figure 1B). To
quantify scar spread 4 to 5 weeks after LAD ligation,
hearts were excised from surviving mice, sectioned,
and stained with Masson’s trichrome. WT and Rad/
mice showed interstitial collagen deposition as pre-
viously described (17), but the extent of scarring was
substantially larger in the WT ventricles compared
with Rad/ (Figures 1C to 1E). Furthermore,
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noninfarcted regions of the heart were found to
contain a greater amount of interstitial fibrosis in WT
compared with Rad/ mice (Figure 1F).
POST-ISCHEMIC CARDIAC FUNCTION IS PRESERVED
IN RADL/L MICE. Given the significant difference in
mortality and remodeling observed between WT and
Rad/ mice, we used echocardiography to measure
changes in function after LAD ligation. Parallel loss of
function occurred in WT and Rad/ hearts after
surgery. Elevated contractility in Rad/ mice in
healthy hearts (prior to LAD ligation) was maintained
24 h after LAD ligation (Table 1, Figures 2A to 2C).
Ejection fraction values (Figure 2B) and fractional
FIGURE 1 Mortality Is Reduced in Rad/ Mice Subjected to Myocardial Infarction, and Rad/ Hearts Have Smaller Scar Size
With Less Fibrosis
(A) Survival curve of wild-type (WT) and Rad/ shows significantly fewer spontaneous deaths in Rad/ mice. *p < 0.05, WT versus Rad/
mice. N ¼ 63 WT myocardial infarction (MI), 75 Rad/ MI, 25 WT sham, and 33 Rad/ sham mice at risk at day 0. After 50 days, there were
58 WT MI mice at risk, and at 100 days, there were 57 WT MI mice at risk; all other counts remained the same as at 0 days. (B) Long-axis
echocardiographic images taken during diastole. Arrows denote boundaries of scar region. (C) Representative hearts fixed after 5 weeks of
ischemia. Arrow indicates suture occluding the left anterior descending coronary artery. (D) Representative sections of post-MI hearts
stained for Masson’s trichrome. Arrows mark interstitial fibrosis. (E) Measurements of scar length in post-MI WT and Rad/ hearts as a
percentage of the left ventricular midline. (F) Interstitial fibrosis score in noninfarcted myocardium (1 ¼ little to no fibrosis, 5 ¼ severe
fibrosis). N ¼ 5 WT and 11 Rad/ mice.
Manning et al. J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 1 , 2 0 1 8
Rad-Loss Results in Multifaceted Post-MI Cardioprotection F E B R U A R Y 2 0 1 8 : 8 3 – 9 6
86
shortening values (Figure 2C) were higher in Rad/
compared to WT mice at any given time point.
Furthermore, improved outcomes were maintained
through 28 days post-surgery (Figures 2A to 2C).
We next measured chamber and wall dimensions.
Enhanced function in Rad/ mice was accompanied
by a significant difference in the degree of progressive
left ventricular chamber dilation and reduced wall
thinning. WT hearts demonstrated progressive dila-
tion of the left ventricular diameter at both diastole
(Figure 2D) and systole (Figure 2E); however, no sig-
nificant dilation was observed in the Rad/ mice at
comparable time points. Similarly, the posterior wall
of the ventricle was significantly thicker in the Rad/
compared with WT mice at 28 days (Figure 2F).
Anterior wall thickness did not reach significance, but
there was a trend toward greater wall thickness in
Rad/ mice (Figure 2G). Taken together, these data
show that Rad contributes to post-MI structural heart
remodeling.
Remodeling in the heart after MI is associated with
increased sympathetic stimulation precipitated by a
reduction in stroke volume and subsequent decrease
in blood pressure. We therefore used echocardiogra-
phy and blood pressure telemetry to determine
whether Rad/ mice exhibited this initial loss of
cardiac output. Cardiac output and stroke volume
were not significantly different between WT and
Rad/ mice prior to surgery (Table 1). However, WT
mice exhibited an initial transient decrease in stroke
volume and cardiac output at 24 h post-surgery, while
cardiac output and stroke volume in Rad/ mice
were preserved (Table 1). In addition, systolic
(Figures 3A and 3B), diastolic (Figures 3C and 3D), and
mean arterial blood pressure (Figures 3E and 3F) in WT
mice dropped significantly after LAD ligation.
Conversely, Rad/ cohorts maintained blood
pressures unchanged from baseline levels and
significantly higher than WT mice at the same time
points.
CALCIUM HANDLING POST-MI IS PRESERVED IN
RADL/L MICE. An important determinant of post-
ischemic loss of function in the heart is progressive
cellular remodeling resulting in impaired calcium
homeostasis. To test whether calcium cycling was
preserved in Rad/ mice, we isolated ventricular
myocytes from adult hearts after LAD ligation and
measured parameters of stimulated calcium release.
We compared WT and Rad/ cellular Ca2þ transients
from hearts after 8 weeks of MI (Figure 4A). Transient
amplitude in the Rad/ MI group was significantly
higher than that of the WT MI counterparts
(Figure 4B). Similarly, sarcomere shortening was
reduced in WT MI but preserved in Rad/ MI
(Figure 4C). In addition, the decay constant (tau) of
the WT MI group was significantly higher than the
sham, suggesting impaired calcium reuptake
(Figure 4D); in contrast, the calcium reuptake kinetics
remained unchanged in the Rad/ MI versus sham
groups (Figure 4D). These results suggest that Rad
deletion prevents functional post-MI remodeling of
calcium handling at the level of the cardiomyocyte.
NO DIFFERENCE WAS OBSERVED IN SUSCEPTIBILITY TO
ISCHEMIC TISSUE DEATH OR PERFUSION BETWEEN WT
AND RADL/L MICE. The significant difference
observed in infarct scar size between WT and Rad/
mice suggested the hypothesis that Rad loss induces
resistance to ischemia-induced cell death in the
border zone of the infarcted heart. Several stimuli
have been associated with a preconditioning-like
resistance to ischemic tissue death (19–21). We
sought to determine whether Rad loss produces a
similar effect. Isolated hearts were subjected to
TABLE 1 Hemodynamics Summary
Heart Rate
(beats/min)
Stroke
Volume (ml)
Cardiac
Output (ml/min)
Ejection
Fraction (%)
Fractional
Shortening (%)
LVIDd
(mm)
LVIDs
(mm)
Baseline
WT 458  8 42  1 20  1 69  1 39  1 3.65  0.05 2.43  0.05
Rad/ 490  7† 41  1 20  1 77  1† 45  1† 3.50  0.04 1.96  0.03
1-day sham
WT 463  9 29  2 14  1 43  4 22  2 3.80  0.16 2.93  0.13
Rad/ 521  11† 31  2 16  1 64  2† 35  1† 3.42  0.06† 2.27  0.07
1-day MI
WT 540  13* 18  2* 10  1* 24  2* 11  1* 4.06  0.16 3.69  0.09
Rad/ 501  10 31  3† 16  1† 48  3*† 24  2*† 3.88  0.14* 2.94  0.13*†
Values are mean  SD. *Significantly different vs. sham at 1 day post-MI. †Significantly different vs. WT at 1 day post-MI.
LVIDd ¼ left ventricular internal dimension in diastole; LVIDs ¼ left ventricular internal dimension in systole; MI ¼ myocardial infarction; WT ¼ wild-type.
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FIGURE 2 Post-Ischemic Loss of Function Is Attenuated in Rad/ Mice
(A) Representative M-mode echocardiographic tracings of wild-type (WT) and Rad/ mice 4 weeks after myocardial infarction (MI). (B,C)
Ejection fraction and fractional shortening for sham and MI (circles and squares, respectively) WT (closed) and Rad/ (open)mice. (D,E) Left
ventricular interior dimension values for WT (closed) and Rad/ (open) at diastole (LVIDd; D) and systole (LVIDs; E). (F) Left ventricular
posterior wall thickness at diastole (LVPWd). (G) Left ventricular anterior wall thickness at diastole (LVAWd). N ¼ 19 MI and 28 sham Rad/
and 30 MI and 38 sham WT mice per group. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 versus WT MI.
Manning et al. J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 1 , 2 0 1 8
Rad-Loss Results in Multifaceted Post-MI Cardioprotection F E B R U A R Y 2 0 1 8 : 8 3 – 9 6
88
15 min of global no-flow ischemia, after which viable
tissue was immediately stained with triphenylte-
trazolium chloride (Figure 5A). No difference in
infarct was observed between WT and Rad/ mice
(Figure 5B), suggesting that Rad loss does not alter
death signaling or initial tissue death but rather
affects the longer term response of the heart to
ischemic damage. We confirmed this finding in vivo
using MI induced by LAD ligation, followed by Evans
blue/triphenyltetrazolium chloride staining and
FIGURE 3 Blood Pressure Is Maintained After Left Anterior Descending Coronary Artery Ligation in Rad/ Mice
(A,C,E) Longitudinal measurements of systolic (A), mean arterial (C), and diastolic (E) blood pressure (BP) in wild-type (WT) and Rad/ mice
before and after left anterior descending coronary artery (LAD) ligation. (B,D,F) Average measurements of systolic (B), mean arterial (D), and
diastolic (F) pressure at baseline prior to surgery, and at single time points of 1, 7, and 25 h after LAD ligation. N ¼ 3 mice per genotype.
**p < 0.01, ***p < 0.001, and ****p < 0.0001 versus baseline; ††p < 0.01 and †††p < 0.01 versus WT at same time point.
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gadolinium magnetic resonance imaging 24 h after
surgery (Figures 5C to 5F). No significant difference
was observed between Rad/ and WT nonperfused
area at risk by Evans blue staining (Figures 5C and 5D)
or infarct development by triphenyltetrazolium
chloride staining (Figure 5E). Furthermore, magnetic
resonance imaging analysis confirmed that no dif-
ference was observed in infarct volume 24 h after MI
(Figure 5G). We also found no difference in 24-h
apoptosis in myocardial sections (Figure 5H).
RADL/L MICE EXHIBIT REDUCED INFLAMMATION
AFTER MI. Post-MI cardiac remodeling occurs step-
wise with an initial acute inflammatory response,
followed by tissue granulation and then scar forma-
tion and spread. Neutrophils are the first immune cell
type to infiltrate the heart following MI (22,23), and
reduced neutrophil extravasation into myocardial
interstitium is linked to protection against MI mor-
tality and scar spread (24,25). Therefore, we next
evaluated neutrophil infiltration as an early indicator
of the post-ischemic inflammatory response. Histo-
logical sections from hearts 24 h post-MI were stained
for Ly6G neutrophils and Ly 6C monocytes with the
marker GR-1 (Figure 6A), and cell density was
measured. We found significantly lower neutrophil
density in Rad/ hearts compared with WT hearts
(Figure 6B). We confirmed the reduction in cardiac
neutrophil density using fluorescence-activated cell
sorting and counting (Figure 6C).
We next examined whether this reduced neutro-
phil density was associated with generalized
FIGURE 4 Calcium Homeostasis Resists Pathological Remodeling in Ventricular Myocytes From Rad/ After Myocardial Infarction
(A) Representative whole-cell Fura-2 recordings for wild-type (WT) and Rad/ myocytes isolated after sham or 14 weeks after left anterior
descending coronary artery ligation. (B) Twitch calcium was significantly lowered in WT cells, as expected, but no change was observed in
Rad/ cells. (C) Fractional shortening was depressed in WT mice after myocardial infarction (MI) but not in Rad/ mice. (D) Decay constant
(tau) is slowed in WT mice by MI but preserved in Rad/ mice. Data represent the averaged values for each mouse taken as the unit of
analysis. N ¼ 16 to 35 cells, n ¼ 9 to 18 mice. *p < 0.05 versus WT sham; †p < 0.01 versus WT MI.
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differences between WT and Rad/ mice for gene
expression induced by MI. We used a Mouse Gene 2.0
ST microarray to identify candidate genes that were
up- or down-regulated in Rad/ ventricular tissue
24 h after MI compared with WT tissue. A plot of all
gene changes illustrates a global differential impact
of MI on WT versus Rad/mice (Figure 7). The overall
pattern of gene expression changes 24 h after
MI suggested that Rad deletion led to a smaller
repertoire of gene changes, including a reduced genes
and pathways involved in inflammatory response
and chemotaxis (data not shown). Proinflammatory
cytokines such as interleukin-6, interleukin-1b, and
tumor necrosis factor–a are not constitutively
expressed in healthy heart but are increased as part of
the innate stress response within 24 h post-MI (26). In
the microarray, interleukin-6, interleukin-1b, Cxcl1,
and Cxcr2 showed comparable, relatively low levels in
healthy heart, and MI induced greater changes in WT
than Rad/ mice (Figure 7, data not shown). To vali-
date and quantify these changes, we performed
quantitative reverse-transcription PCR of selected
FIGURE 5 Rad/ Hearts Are Not Protected From Ischemic Cell Death
(A) Representative images of sequential short-axis heart sections from hearts subjected to global no-flow ischemia stained with 0.1%
triphenyltetrazolium chloride (TTC) revealing viable (red) and nonviable (white or beige)myocardium. (B) Quantification of infarct volume as
a percentage of heart volume shows no difference in infarct development between wild-type (WT) and Rad/ hearts. N ¼ 8 mice per group.
(C) Representative images of heart sections 24 h after LAD ligation stained with Evans blue/TTC. Blue area is perfused tissue, red area
indicates living nonperfused tissue, and white/beige area is infarcted (nonviable) tissue. (D,E) Quantification of area at risk (AAR) and infarct
reveals no difference in nonperfused tissue area or infarct development between WT and Rad/ hearts. (F) Gadolinium magnetic resonance
imaging of infarcted hearts also reveals comparable infarction at 24 h between WT and Rad/ mice. (G) No difference is observed in 24-h
apoptosis staining. White arrows show apoptotic cells. N ¼ 8 mice per group.
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inflammation-related genes (Figures 8A to 8F). We also
observed in the Rad/mice significantly higher levels
of basal expression of thrombospondin-4, a protein
that has previously been identified as a myocyte-
generated anti-inflammatory agent (Figure 8G),
although no further induction was observed in Rad/
mice after MI (Figure 8H).
DISCUSSION
The main finding of this study is that deletion of
Rad protects the heart against MI. In Rad-knockout
mice, scar spread is limited, cardiac function re-
mains higher, and at the level of cardiomyocyte
cellular physiology, there is no evidence for path-
ological post-MI functional remodeling. Rad dele-
tion confers a functional advantage prior to MI that
is retained following MI. This study also suggests
that Rad may contribute to the inflammatory
response following MI. Consequently, Rad/ mice
show cardioprotection secondary to the combina-
tion of elevated function prior to MI and attenu-
ated inflammation-induced post-MI cardiac
remodeling.
FIGURE 6 Neutrophil Counts Are Reduced in Rad/ Myocardium Compared With Wild-Type After 24 h Myocardial Infarction
(A) Representative images of myocardium stained for Gr-1 as an indicator of neutrophils (white cells). (B) Quantification of neutrophil density
of 10 averaged random micrographs. N ¼ 5 hearts. (C) Fluorescence-activated cell sorting and counting of neutrophil marker–tagged cells in
digested hearts. N ¼ 3 sham, 4 wild-type (WT) myocardial infarction (MI) and Rad/ MI hearts. *p < 0.05 versus WT sham group.
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The Rad/ heart has stable elevated function
compared with WT (12,27). This functional gain is
preserved 24 h after LAD ligation, although there is a
parallel reduction of function in both Rad/ and MI
(Figure 2). Nevertheless, function in the Rad/ mice
appears to be sufficiently preserved to avoid the
precipitous drop in cardiac output and blood pressure
observed in WT mice (Figure 3). This acute preser-
vation of function occurs prior to scar spread and
myocardial remodeling, suggesting that the improved
inotropy associated with Rad deletion (12,27) is
maintained after AMI. In WT mice after MI, loss of
function results in reflexive, tonic elevation of
sympathetic drive that causes pathological car-
diomyocyte remodeling. However, the absence of
impaired calcium cycling suggests that Rad deletion
sufficiently preserves cardiac output to avoid cyto-
logical remodeling. This along with earlier findings
that Rad/ is neither arrhythmogenic (12) nor prone
to pathological growth (17) draws attention to the
new paradigm that distinct regulation of LTCC can be
beneficial by improving Ca2þ homeostasis (28). In
sharp contrast, elevating LTCC via CaVb2 over-
expression enhanced cardiomyocyte trigger Ca2þ but
led to reduced heart function secondary to car-
diomyocyte death (29).
An early study of the Rad/ mouse showed
increased hypertrophy (13); however, it is important
to note that this early work performed no functional
evaluations. We have now documented stable,
chronic positive inotropic function that phenocopies
b-adrenergic receptor stimulation in Rad-deficient
mice into aging (17,27). Our studies suggest the
importance of reevaluating whether Rad-increased
Ca2þ homeostasis, along with modest cardiac hyper-
trophy, can form a basis for future safe, stable posi-
tive inotropic therapeutic directions.
The loss of Rad may protect the heart from MI in
part by blocking the pathological progression of
inflammation that follows the initial ischemic insult.
The onset of MI is typically followed by a rapid influx
of neutrophils, peaking around 24 h after MI (30).
Neutrophils then undergo apoptosis, releasing cyto-
kines and chemokines that trigger the infiltration of
monocytes and macrophages several days after the
beginning of ischemia that clear the dying neutro-
phils and release cytokines that promote fibrosis and
scar formation (24). The impact of this process on
healing and outcomes of the heart is complex;
although blocking late monocyte infiltration has been
shown to be injurious (31), previous experiments have
also suggested that blocking neutrophil extravasation
is protective against early cardiac rupture and
pathological remodeling post-MI (32). We propose
that in this global Rad/ knockout, we observe pro-
tection against MI-induced pathological remodeling
at 2 levels: we observe both a dampened inflamma-
tory response after LAD ligation leading to reduced
remodeling and an earlier preservation at 24 h post-
MI of the improved contractility in Rad/ before
the effects of inflammation would be expected
to affect function. These 2 effects may also be
interconnected, given that an important trigger for
neutrophil extravasation and inflammation is the
sympathetic nervous system, which is activated in
the presence of depressed cardiac output (33).
Whether the dampened immune response is due to
the preservation of sufficient cardiac output to
circumvent adrenergic-driven induction and mobili-
zation of neutrophils or whether the global loss of Rad
directly affects the maturation and release of neu-
trophils from bone marrow or spleen remains to be
determined. We designed the microarray study to
enable discovery of putative signaling pathways that
attenuate scar spread and pathological myocardial
remodeling in the Rad/ mouse. Follow-up quanti-
tative reverse-transcription PCR directed by the
combination of pathway enrichment analysis and
neutrophil extravasation assays (Figures 6 to 8) re-
inforces the utility of our approach to the microarray
study.
FIGURE 7 More Genes Change to a Greater Extent in Wild-Type Myocardium
Compared With Rad/ After 24 h Myocardial Infarction
Scattergram of fold change as a function of signal intensity for 24 h after myocardial
infarction (MI). Wild-type (WT) (blue dots) and Rad/ (red dots). Position of selected
genes used for quantitative reverse-transcription polymerase chain reaction analysis
are highlighted (WT, black arrows; Rad/, red arrows). IL1b ¼ interleukin-1b;
IL ¼ interleukin; mRNA ¼ messenger ribonucleic acid.
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The observed decrease in early mortality (2 to 5
days) post-MI due to ventricle rupture in Rad/ mice
is consistent with an attenuated inflammatory
response as well. Numerous previous studies have
demonstrated a significant role for early inflammatory
responses in the incidence of rupture, a catastrophic
complication of MI that has been described in both
mice and humans (34–37). However, it is important to
note that deletion of Rad produces a nonpathological
increase cardiac wall thickness with mild interstitial
fibrosis (17,27). An interesting question that remains is
whether these changes in ventricular morphology
might work synergistically with reduced inflammatory
responses in the Rad/ to prevent tearing of the wall.
The Rad/ phenotype has similarities to a car-
diac specific knockout of the transforming growth
factor–b receptors (32). The transforming growth
factor–b receptor knockout model is similarly pro-
tected against acute cardiac rupture–associated
mortality and scar elongation in a manner that is
associated with decreased neutrophil infiltration of
the myocardium at early time points after MI. Given
that Rad is produced primarily in the cardiomyocyte
and not found in observable levels in cardiac
fibroblasts (38), Rad and transforming growth
factor–b may similarly act as repressors of
thrombospondin-4 transcription in myocytes. We
note that unlike transforming growth factor–b, we
do not observe a difference in thrombospondin-4
expression after MI, suggesting that the hearts of
Rad/ mice may be primed to reduce the inflam-
matory response prior to ischemic insult, rather
FIGURE 8 Induction of Inflammatory Cytokines Up-Regulated After Myocardial Infarction Is Significantly Reduced in Rad/ Hearts
Up-regulation of inflammatory cytokines Il-16 (A), Il-1b (B), Cxcr2 (C), Cxcl1 (D), and Cxcl2 (E) is significantly mitigated after myocardial
infarction (MI) in Rad/ compared with wild-type (WT) mice. Similarly, a trend toward reduction in Tnfa (F) is also observed but does not
reach significance. (G) Thrombospondin-4 is significantly up-regulated in Rad/mice prior to MI, but levels are uniformly high in both Rad/
and WT mice after left anterior descending coronary artery ligation (H). N ¼ 3 mice per sham, n ¼ 5 mice per MI per genotype. *p < 0.05,
**p < 0.01,***p < 0.001, and ****p < 0.0001 versus WT baseline; †p < 0.05 and ††p < 0.01 versus WT MI.
Manning et al. J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 1 , 2 0 1 8
Rad-Loss Results in Multifaceted Post-MI Cardioprotection F E B R U A R Y 2 0 1 8 : 8 3 – 9 6
94
than up-regulate thrombospondin-4 expression after
ischemic insult.
CONCLUSIONS
We show here that loss of Rad results in multifaceted
protection against post-ischemic remodeling. First,
we observe mitigated indexes of post-ischemic failure
in both contractile function and ventricular remod-
eling, concurrent with a preservation of cellular
calcium handling. We also observe decreased scar
size without decreased infarct volumes, suggesting a
dampening of scar elongation processes. This occurs
in conjunction with an attenuated inflammatory
response, which is further confirmed by decreased
neutrophilia in the heart and reduced expression of
inflammatory cytokines.
ADDRESS FOR CORRESPONDENCE: Dr. Jonathan
Satin, Department of Physiology, MS-508, University of
KentuckyCollegeofMedicine,800RoseStreet,Lexington,
Kentucky 40536-0298. E-mail: jsatin1@uky.edu.
RE F E RENCE S
1. Dhalla NS, Rangi S, Babick AP, Zieroth S,
Elimban V. Cardiac remodeling and subcellular
defects in heart failure due to myocardial infarc-
tion and aging. Heart Failure Reviews 2012;17:
671–81.
2. Konstam MA, Kramer DG, Patel AR, Maron MS,
Udelson JE. Left ventricular remodeling in heart
failure: current concepts in clinical significance
and assessment. J Am Coll Cardiol Img 2011;4:
98–108.
3. Zhang X, Szeto C, Gao E, et al. Cardiotoxic
and cardioprotective features of chronic beta-
adrenergic signaling. Circ Res 2013;112:
498–509.
4. Unverferth D, Magorien R, Lewis R, Leier C.
Long-term benefit of dobutamine in patients with
congestive cardiomyopathy. Am Heart J 1980;100:
622–30.
5. Frishman WH, Saunders E. b-Adrenergic
blockers. J Clin Hypertens 2011;13:649–53.
6. Killip T, Kimball JT. Treatment of myocardial
infarction in a coronary care unit. A two year
experience with 250 patients. Am J Cardiol 1967;
20:457–64.
7. Finlin BS, Correll RN, Pang C, Crump SM, Satin J,
Andres DA. Analysis of the complex between Ca2þ
channel beta-subunit and the Rem GTPase. J Biol
Chem 2006;281:23557–66.
8. Correll RN, Botzet GJ, Satin J, Andres DA,
Finlin BS. Analysis of the Rem2–voltage depen-
dent calcium channel beta subunit interaction
and Rem2 interaction with phosphorylated
phosphatidylinositide lipids. Cell Signal 2008;20:
400–8.
9. Crump SM, Correll RN, Schroder EA, et al.
L-type calcium channel alpha-subunit and protein
kinase inhibitors modulate Rem-mediated regula-
tion of current. Am J Physiol Heart Circ Physiol
2006;291:H1959–71.
10. Finlin BS, Andres DA. Rem is a new member
of the Rad- and Gem/Kir Ras-related GTP-
binding protein family repressed by lipopoly-
saccharide stimulation. J Biol Chem 1997;272:
21982–8.
11. Finlin BS, Crump SM, Satin J, Andres DA.
Regulation of voltage-gated calcium channel
activity by the Rem and Rad GTPases. Proc Natl
Acad Sci U S A 2003;100:14469–74.
12. Manning JR, Yin G, Kaminski CN, et al. Rad
GTPase deletion increases L-type calcium channel
current leading to increased cardiac contraction.
J Am Heart Assoc 2013;2:e000459.
13. Chang L, Zhang J, Tseng YH, et al. Rad GTPase
deficiency leads to cardiac hypertrophy. Circula-
tion 2007;116:2976–83.
14. Becker RC, Burns M, Gore JM, et al. Early
assessment and in-hospital management of
patients with acute myocardial infarction at
increased risk for adverse outcomes: a nationwide
perspective of current clinical practice. The Na-
tional Registry of Myocardial Infarction (NRMI-2)
Participants. Am Heart J 1998;135:786–96.
15. Steg PG, Dabbous OH, Feldman LJ, et al. De-
terminants and prognostic impact of heart failure
complicating acute coronary syndromes. Obser-
vations from the Global Registry of Acute Coro-
nary Events (GRACE) 2004;109:494–9.
16. Zouggari Y, Ait-Oufella H, Bonnin P, et al.
B lymphocytes trigger monocyte mobilization and
impair heart function after acute myocardial
infarction. Nat Med 2013;19:1273–80.
17. Manning JR, Withers CN, Levitan B, Smith JD,
Andres DA, Satin J. Loss of Rad-GTPase produces a
novel adaptive cardiac phenotype resistant to
systolic decline with aging. Am J Physiol Heart Circ
Physiol 2015;309:H1336–45.
18. Gao E, Koch WJ. A novel and efficient model of
coronary artery ligation in the mouse. Methods
Mol Biol 2013;1037:299–311.
19. Miki T, Cohen MV, Downey JM. Opioid receptor
contributes to ischemic preconditioning through
protein kinase C activation in rabbits. Mol Cell
Biochem 1998;186:3–12.
20. Akita T, Abe T, Kto S, Kodama I, Toyama J. Pro-
tective effects of diltiazem and ryanodine against
ischemia-reperfusion injury in neonatal rabbit hearts.
J Thorac Cardiovasc Surg 1993;106:55–66.
21. Ramesh V, Snehasikta S, Mahesh T, Samson
Mathews S, Nilanjana M. Ex vivo and in vivo ap-
proaches to study mechanisms of cardioprotection
targeting ischemia/reperfusion (I/R) injury: useful
techniques for cardiovascular drug discovery. Curr
Drug Discov Technol 2008;5:269–78.
22. Yan X, Anzai A, Katsumata Y, et al. Temporal
dynamics of cardiac immune cell accumulation
following acute myocardial infarction. J Mol Cell
Cardiol 2013;62:24–35.
23. Frangogiannis NG. Regulation of the inflam-
matory response in cardiac repair. Circ Res 2012;
110:159–73.
24. Frodermann V, Nahrendorf M. Neutrophil–
macrophage cross-talk in acute myocardial
infarction. Eur Heart J 2017;38:198–200.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: AMI causes
death and remodeling of heart cells leading to heart failure and
arrhythmias. Therapeutic options such as those that target the
b-adrenergic signaling axis paradoxically reduce heart function.
LTCCs provide trigger Ca2þ to transduce electric excitation into
contraction. Increased LTCC function is a positive inotrope and
contributes to heart growth.
TRANSLATIONAL OUTLOOK: The protein Rad interacts
with the LTCC to modulate trigger Ca2þ and hence to limit
contractility. Future studies to target the deletion of Rad in
the heart could be conducted to establish a novel treatment
paradigm whereby pathologically stressed hearts would be given
safe, stable positive inotropic support without arrhythmias
and without pathological structural remodeling. Future investi-
gations will also focus on establishing inhibitors of Rad and on
testing the efficacy of Rad deletion in cardioprotection relative to
the time of onset of AMI.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 1 , 2 0 1 8 Manning et al.
F E B R U A R Y 2 0 1 8 : 8 3 – 9 6 Rad-Loss Results in Multifaceted Post-MI Cardioprotection
95
25. Arruda-Olson AM, Reeder GS, Bell MR,
Weston SA, Roger VL. Neutrophilia predicts death
and heart failure after myocardial infarction: a
community-based study. Circ Cardiovasc Qual
Outcomes 2009;2:656–62.
26. Nian M, Lee P, Khaper N, Liu P. Inflammatory
cytokines and postmyocardial infarction remodel-
ing. Circ Res 2004;94:1543–53.
27. Levitan BM, Manning JR, Withers CN, et al.
Rad-deletion phenocopies tonic sympathetic
stimulation of the heart. J Cardiovasc Transl Res
2016;9:432–44.
28. Raake PW, Zhang X, Vinge LE, et al.
Cardiac G-protein–coupled receptor kinase 2
ablation induces a novel Ca2þ handling phenotype
resistant to adverse alterations and remodeling
after myocardial infarction. Circulation 2012;125:
2108–18.
29. Zhang H, Chen X, Gao E, et al. Increasing
cardiac contractility after myocardial infarction
exacerbates cardiac injury and pump dysfunction.
Circ Res 2010;107:800–9.
30. Jung K, Kim P, Leuschner F, et al. Endoscopic
time-lapse imaging of immune cells in infarcted
mouse hearts: novelty and significance. Circ Res
2013;112:891–9.
31. Nahrendorf M, Swirski FK, Aikawa E, et al. The
healing myocardium sequentially mobilizes two
monocyte subsets with divergent and comple-
mentary functions. J Exp Med 2007;204:
3037–47.
32. Rainer PP, Hao S, Vanhoutte D, et al. Car-
diomyocyte-specific transforming growth factor b
suppression blocks neutrophil infiltration, aug-
ments multiple cytoprotective cascades, and
reduces early mortality after myocardial infarc-
tion: novelty and significance. Circ Res 2014;114:
1246–57.
33. Irwin MR, Cole SW. Reciprocal regulation of
the neural and innate immune systems. Nat Rev
Immunol 2011;11:625–32.
34. Gao X-M, White DA, Dart AM, Du X-J. Post-
infarct cardiac rupture: Recent insights on patho-
genesis and therapeutic interventions. Pharmacol
Ther 2012;134:156–79.
35. Heymans S, Luttun A, Nuyens D, et al. Inhibi-
tion of plasminogen activators or matrix metal-
loproteinases prevents cardiac rupture but impairs
therapeutic angiogenesis and causes cardiac
failure. Nat Med 1999;5:1135–42.
36. Pouleur A-C, Barkoudah E, Uno H, et al.
Pathogenesis of sudden unexpected death in a
clinical trial of patients with myocardial infarction
and left ventricular dysfunction, heart failure, or
both: clinical perspective. Circulation 2010;122:
597–602.
37. Roberts WC, Burks KH, Ko JM, Filardo G,
Guileyardo JM. Commonalities of cardiac rupture
(left ventricular free wall or ventricular septum or
papillary muscle) during acute myocardial infarc-
tion secondary to atherosclerotic coronary artery
disease. Am J Cardiol 2015;115:125–40.
38. Zhang J, Chang L, Chen C, et al. Rad GTPase
inhibits cardiac fibrosis through connective tissue
growth factor. Cardiovasc Res 2011;91:90–8.
KEY WORDS calcium channel,
cardioprotection, inflammation, myocardial
infarction
APPENDIX For supplemental methods,
please see the online version of this paper.
Manning et al. J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 1 , 2 0 1 8
Rad-Loss Results in Multifaceted Post-MI Cardioprotection F E B R U A R Y 2 0 1 8 : 8 3 – 9 6
96
